• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

澳门基层医疗环境中血脂异常管理审核项目的有效性:一项质量改进研究。

Effectiveness of an audit programme for dyslipidaemia management in a primary care setting in Macau: a quality improvement study.

作者信息

Wong In, Tse See Fai, Kwok Chau Sha

机构信息

Health Bureau, Macau SAR Government, Macau, China.

出版信息

Fam Med Community Health. 2020 Feb 24;8(1):e000222. doi: 10.1136/fmch-2019-000222. eCollection 2020.

DOI:10.1136/fmch-2019-000222
PMID:32148732
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7046378/
Abstract

OBJECTIVE

The objective of this study was to test the effectiveness of an audit programme for dyslipidaemia management in a primary care setting in Macau.

DESIGN

A quality improvement study based on an evaluation of a before-after intervention trial was conducted in 2017-2018. Interventions comprising feedback from an audit, general practitioner (GP) training via interactive workshops and one-on-one case discussions were implemented. The primary outcome measure was the proportion of patients with reasonable management of dyslipidaemia, and the secondary outcome measure was the proportion of patients with low-density lipoprotein cholesterol (LDL-C) meeting the target recommended by the Adult Treatment Panel III guidelines.

SETTING

This study was conducted at the Sao Lourenco Health Center, one of the health centres in the Macau primary care system; this centre provides primary care services to one-tenth of the residents of Macau.

PARTICIPANTS

All GPs who worked in the Sao Lourenco Health Center participated in the study. We systematically reviewed 100 patient records from each participating physician's patient list. In total, 1200 and 1100 patient records were reviewed before and after the intervention, respectively.

RESULTS

At baseline, 390 (43.5%) patients were eligible for statin therapy, while 411 (47.7%) patients were eligible for statin therapy in the reaudit group (p=0.08). After intervention, the proportion of patients with reasonable management of dyslipidaemia increased from 83.9% to 88.5% (p=0.005), and the proportion of eligible patients with LDL-C levels meeting the target increased from 55.1% to 65% (p=0.004).

CONCLUSIONS

The audits and feedback significantly improved dyslipidaemia management in the Macau primary care setting.

摘要

目的

本研究旨在测试澳门基层医疗环境中血脂异常管理审核计划的有效性。

设计

2017年至2018年进行了一项基于前后干预试验评估的质量改进研究。实施了包括审核反馈、通过互动研讨会进行全科医生培训以及一对一病例讨论在内的干预措施。主要结局指标是血脂异常管理合理的患者比例,次要结局指标是低密度脂蛋白胆固醇(LDL-C)达到成人治疗小组III指南推荐目标的患者比例。

背景

本研究在澳门基层医疗系统中的健康中心之一圣若伦索健康中心进行;该中心为澳门十分之一的居民提供基层医疗服务。

参与者

所有在圣若伦索健康中心工作的全科医生参与了本研究。我们系统地审查了每位参与医生患者名单中的100份患者记录。干预前后分别共审查了1200份和1100份患者记录。

结果

基线时,390名(43.5%)患者符合他汀类药物治疗条件,而重新审核组中有411名(47.7%)患者符合他汀类药物治疗条件(p = 0.08)。干预后,血脂异常管理合理的患者比例从83.9%增至88.5%(p = 0.005),符合条件且LDL-C水平达标的患者比例从55.1%增至65%(p = 0.004)。

结论

审核和反馈显著改善了澳门基层医疗环境中的血脂异常管理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc96/7046378/b27ea0c3e514/fmch-2019-000222f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc96/7046378/b27ea0c3e514/fmch-2019-000222f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc96/7046378/b27ea0c3e514/fmch-2019-000222f01.jpg

相似文献

1
Effectiveness of an audit programme for dyslipidaemia management in a primary care setting in Macau: a quality improvement study.澳门基层医疗环境中血脂异常管理审核项目的有效性:一项质量改进研究。
Fam Med Community Health. 2020 Feb 24;8(1):e000222. doi: 10.1136/fmch-2019-000222. eCollection 2020.
2
Management of Low Density Lipoprotein Cholesterol at a primary care diabetes clinic in Kuwait.科威特基层医疗糖尿病诊所的低密度脂蛋白胆固醇管理。
Prim Care Diabetes. 2019 Jun;13(3):259-265. doi: 10.1016/j.pcd.2018.11.003. Epub 2018 Dec 19.
3
The impact of a disease management program (COACH) on the attainment of better cardiovascular risk control in dyslipidaemic patients at primary care centres (The DISSEMINATE Study): a randomised controlled trial.疾病管理项目(COACH)对初级保健中心血脂异常患者实现更好心血管风险控制的影响(DISSEMINATE 研究):一项随机对照试验。
BMC Fam Pract. 2012 Oct 10;13:97. doi: 10.1186/1471-2296-13-97.
4
Effectiveness and safety of ezetimibe added to statin therapy in patients with primary dyslipidaemia not achieving the LDL-C treatment goal on statin monotherapy.在接受他汀类单药治疗未达到低密度脂蛋白胆固醇(LDL-C)治疗目标的原发性血脂异常患者中,添加依折麦布至他汀类治疗的有效性和安全性。
Clin Drug Investig. 2007;27(5):333-7. doi: 10.2165/00044011-200727050-00004.
5
Cholesterol levels and statin use in patients with coronary heart disease treated in primary care settings.在初级保健机构接受治疗的冠心病患者的胆固醇水平及他汀类药物使用情况。
Prev Chronic Dis. 2005 Jul;2(3):A05. Epub 2005 Jun 15.
6
Feedback GAP: pragmatic, cluster-randomized trial of goal setting and action plans to increase the effectiveness of audit and feedback interventions in primary care.反馈差距:以目标设定和行动计划为干预手段,提高初级保健中审核反馈干预效果的实用、整群随机试验。
Implement Sci. 2013 Dec 17;8:142. doi: 10.1186/1748-5908-8-142.
7
Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.在老年患者中,依折麦布联合他汀类药物持续治疗对改善血脂谱及实现低密度脂蛋白胆固醇目标的有效性:一项随机、双盲、安慰剂对照试验数据的亚组分析
Am J Geriatr Pharmacother. 2005 Dec;3(4):218-28.
8
Effectiveness of treat-to-target strategy for LDL-cholesterol control in type 2 diabetes: post-hoc analysis of data from the MIND.IT study.2型糖尿病患者低密度脂蛋白胆固醇控制的达标治疗策略有效性:来自MIND.IT研究数据的事后分析
Eur J Prev Cardiol. 2014 Apr;21(4):456-63. doi: 10.1177/2047487312467746. Epub 2012 Nov 12.
9
Individualized Risk Communication and Outreach for Primary Cardiovascular Disease Prevention in Community Health Centers: Randomized Trial.社区卫生中心原发性心血管疾病预防的个性化风险沟通与推广:随机试验
Circ Cardiovasc Qual Outcomes. 2015 Nov;8(6):560-6. doi: 10.1161/CIRCOUTCOMES.115.001723. Epub 2015 Nov 10.
10
Single and mixed dyslipidaemia in Canadian primary care settings: findings from the Canadian primary care sentinel surveillance network database.加拿大初级保健机构中的单纯性和混合性血脂异常:来自加拿大初级保健哨点监测网络数据库的研究结果。
BMJ Open. 2015 Dec 11;5(12):e007954. doi: 10.1136/bmjopen-2015-007954.

引用本文的文献

1
Impact of Implementing a Dyslipidemia Management Guideline on Cholesterol Control for Secondary Prevention of Ischemic Heart Disease in Primary Care.实施血脂异常管理指南对初级保健中缺血性心脏病二级预防的胆固醇控制的影响。
Int J Environ Res Public Health. 2020 Nov 19;17(22):8590. doi: 10.3390/ijerph17228590.

本文引用的文献

1
Legacy effects of statins on cardiovascular and all-cause mortality: a meta-analysis.他汀类药物对心血管和全因死亡率的遗留效应:荟萃分析。
BMJ Open. 2018 Oct 4;8(9):e020584. doi: 10.1136/bmjopen-2017-020584.
2
Statins for Prevention of Cardiovascular Disease in Adults: Evidence Report and Systematic Review for the US Preventive Services Task Force.他汀类药物用于成人心血管疾病预防:美国预防服务工作组的证据报告和系统评价
JAMA. 2016 Nov 15;316(19):2008-2024. doi: 10.1001/jama.2015.15629.
3
Statins for the prevention of stroke: a meta-analysis of randomized controlled trials.
他汀类药物预防中风:随机对照试验的荟萃分析。
PLoS One. 2014 Mar 18;9(3):e92388. doi: 10.1371/journal.pone.0092388. eCollection 2014.
4
Results of the Dyslipidemia International Study (DYSIS)-Middle East: clinical perspective on the prevalence and characteristics of lipid abnormalities in the setting of chronic statin treatment.血脂异常国际研究(DYSIS)-中东地区结果:慢性他汀类药物治疗背景下血脂异常的流行情况和特征的临床观察。
PLoS One. 2014 Jan 6;9(1):e84350. doi: 10.1371/journal.pone.0084350. eCollection 2014.
5
Statins for the primary prevention of cardiovascular disease.他汀类药物用于心血管疾病的一级预防。
Cochrane Database Syst Rev. 2013 Jan 31;2013(1):CD004816. doi: 10.1002/14651858.CD004816.pub5.
6
Audit and feedback: effects on professional practice and healthcare outcomes.审核与反馈:对专业实践和医疗结果的影响。
Cochrane Database Syst Rev. 2012 Jun 13;2012(6):CD000259. doi: 10.1002/14651858.CD000259.pub3.
7
Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study.在欧洲的临床实践中实现心血管疾病一级预防的治疗目标:EURIKA 研究。
Eur Heart J. 2011 Sep;32(17):2143-52. doi: 10.1093/eurheartj/ehr080. Epub 2011 Apr 6.
8
Meta-analysis: audit and feedback features impact effectiveness on care quality.荟萃分析:审核与反馈特征对医疗质量的有效性产生影响。
Med Care. 2009 Mar;47(3):356-63. doi: 10.1097/MLR.0b013e3181893f6b.
9
General cardiovascular risk profile for use in primary care: the Framingham Heart Study.用于初级保健的一般心血管风险概况:弗雷明汉心脏研究
Circulation. 2008 Feb 12;117(6):743-53. doi: 10.1161/CIRCULATIONAHA.107.699579. Epub 2008 Jan 22.
10
Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis.他汀类药物14项随机试验中18686例糖尿病患者降脂治疗的疗效:一项荟萃分析。
Lancet. 2008 Jan 12;371(9607):117-25. doi: 10.1016/S0140-6736(08)60104-X.